Global Tests in Evaluation of the Function of Proand Anticoagulant Systems: Present and Future
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 605536597 | ||
| 003 | CHVBK | ||
| 005 | 20210128100853.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 210128e20150601xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1007/s10517-015-2923-8 |2 doi |
| 035 | |a (NATIONALLICENCE)springer-10.1007/s10517-015-2923-8 | ||
| 245 | 0 | 0 | |a Global Tests in Evaluation of the Function of Proand Anticoagulant Systems: Present and Future |h [Elektronische Daten] |c [V. Udut, I. Tyutrin, M. Solov'ev, V. Klimenkova, E. Malyugin, O. Karchagina, E. Borodulina, A. Turenko] |
| 520 | 3 | |a Comparative analysis of the effectiveness of global tests for evaluation of the blood coagulation systems demonstrated the possibility of obtaining express data on hemostasis stages I-II and III when working with native substrate (whole blood). Changes in viscous characteristics of the whole blood recorded ex vivo during hemocoagulation allowed us to propose the concept of permanency of fibrinogenesis as the obligatory in vivo process determining the hemostatic potential, an integral characteristic of the hemocoagulation cycle providing sufficient blood fluidity and limiting extravasation of blood components under conditions of permeability disturbances and damage to the vascular wall. | |
| 540 | |a Springer Science+Business Media New York, 2015 | ||
| 690 | 7 | |a hemocoagulation |2 nationallicence | |
| 690 | 7 | |a hemostatic potential |2 nationallicence | |
| 690 | 7 | |a whole blood |2 nationallicence | |
| 690 | 7 | |a global tests |2 nationallicence | |
| 690 | 7 | |a low-frequency piezoelectric thromboelastography |2 nationallicence | |
| 700 | 1 | |a Udut |D V. |u E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk, Russia |4 aut | |
| 700 | 1 | |a Tyutrin |D I. |u Mednord-Tekhnika, Tomsk, Russia |4 aut | |
| 700 | 1 | |a Solov'ev |D M. |u E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk, Russia |4 aut | |
| 700 | 1 | |a Klimenkova |D V. |u Mednord-Tekhnika, Tomsk, Russia |4 aut | |
| 700 | 1 | |a Malyugin |D E. |u Mednord-Tekhnika, Tomsk, Russia |4 aut | |
| 700 | 1 | |a Karchagina |D O. |u E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk, Russia |4 aut | |
| 700 | 1 | |a Borodulina |D E. |u E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk, Russia |4 aut | |
| 700 | 1 | |a Turenko |D A. |u Mednord-Tekhnika, Tomsk, Russia |4 aut | |
| 773 | 0 | |t Bulletin of Experimental Biology and Medicine |d Springer US; http://www.springer-ny.com |g 159/2(2015-06-01), 205-208 |x 0007-4888 |q 159:2<205 |1 2015 |2 159 |o 10517 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s10517-015-2923-8 |q text/html |z Onlinezugriff via DOI |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 900 | 7 | |a Metadata rights reserved |b Springer special CC-BY-NC licence |2 nationallicence | |
| 908 | |D 1 |a research-article |2 jats | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-springer | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1007/s10517-015-2923-8 |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Udut |D V. |u E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Tyutrin |D I. |u Mednord-Tekhnika, Tomsk, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Solov'ev |D M. |u E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Klimenkova |D V. |u Mednord-Tekhnika, Tomsk, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Malyugin |D E. |u Mednord-Tekhnika, Tomsk, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Karchagina |D O. |u E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Borodulina |D E. |u E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Turenko |D A. |u Mednord-Tekhnika, Tomsk, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t Bulletin of Experimental Biology and Medicine |d Springer US; http://www.springer-ny.com |g 159/2(2015-06-01), 205-208 |x 0007-4888 |q 159:2<205 |1 2015 |2 159 |o 10517 | ||